Granuloma
Showing 1 - 25 of 601
Granuloma, Pyogenic, Cryotherapy Effect Trial in Graz (Cryopen - Cryotherapy)
Recruiting
- Granuloma, Pyogenic
- Cryotherapy Effect
- Cryopen - Cryotherapy
-
Graz, Styria, AustriaMedical University of Graz
Jan 11, 2023
Granuloma Annulare Trial in New Haven (Abrocitinib 200 mg)
Not yet recruiting
- Granuloma Annulare
- Abrocitinib 200 mg
-
New Haven, ConnecticutYale University
Dec 19, 2022
Evaluation of 41 Cases of Pediatric Granuloma Annulare
Completed
- Granuloma Annulare
-
Istanbul, TurkeyIstanbul Training and Research Hospital
Jul 21, 2022
Granuloma Annulare Trial in New Haven (AC-1101)
Recruiting
- Granuloma Annulare
-
New Haven, ConnecticutYale Center for Clinical Investigation
Nov 2, 2022
Umbilical Granuloma Trial in Islamabad (Doxycyclin, COMMON SALT)
Completed
- Umbilical Granuloma
- Doxycyclin
- COMMON SALT
-
Islamabad, PakistanPakistan institute of medical Sciences/ Shaheed Zulfiqar Ali Bhu
Sep 16, 2022
JAK/STAT Pathway in Sarcoidosis Granuloma Cells
Recruiting
- Sarcoidosis
- JAK-STAT Pathway Deregulation
- Blood sample
-
Bobigny, FranceService de pneumologie Hôpital Avicenne
Oct 3, 2022
Granuloma, Aluminum Allergy Trial in Hellerup (Aluminum, Tetanus toxoid)
Completed
- Granuloma
- Aluminum Allergy
- Aluminum
- Tetanus toxoid
-
Hellerup, DenmarkNational Allergy Research Centre, Gentofte Hospital
Nov 8, 2023
Pulp and Periapical Tissue Disease, Pulp Necroses, Pulp; Granuloma Trial in Cairo (Conventional group (NaOCl/EDTA), Dual laser
Completed
- Pulp and Periapical Tissue Disease
- +2 more
- Conventional group (NaOCl/EDTA)
- +2 more
-
Cairo, Abbassia, EgyptAin Shams University
Jul 25, 2023
Pyogenic Granuloma of Gingiva Trial in Alexandria (diode laser application, intra-lesional injection of ethanolamine oleate)
Completed
- Pyogenic Granuloma of Gingiva
- diode laser application
- intra-lesional injection of ethanolamine oleate
-
Alexandria, EgyptFaculty of dentistry, Alexandria University
Oct 18, 2021
Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and
Recruiting
- Granuloma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Subjects With Chronic Granulomatous Disease (CGD)
Recruiting
- Chronic Granulomatous Disease
- Specimen Donation
-
Woburn, MassachusettsSanguine BioSciences, Inc.
Jun 14, 2023
Cutaneous Sarcoidosis, Granuloma Annulare Trial in New Haven (Tofacitinib 5 mg twice daily)
Completed
- Cutaneous Sarcoidosis
- Granuloma Annulare
- Tofacitinib 5 mg twice daily
-
New Haven, ConnecticutYale Center for Clinical Investigation
Jul 13, 2021
Teeth, Endodontically-Treated, Tooth, Nonvital, Periapical Periodontitis, Chronic Nonsuppurative Trial in Itabuna (RCT-SV,
Recruiting
- Teeth, Endodontically-Treated
- +3 more
- RCT-SV
- +2 more
-
Itabuna, Bahia, BrazilModerne Odontolgia
Feb 15, 2022
Factors Affecting the Endodontic Treatment Outcome
Recruiting
- Apical Periodontitis
- +2 more
- primary endodontic treatment
-
Ljubljana, SloveniaOdontos, specialistična zobna ambulanta, d.o.o.
Jan 22, 2022
Patients Treated for Chronic Granulomatous Disease Since January
Completed
- Chronic Granulomatous Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 1, 2022
Chronic Granulomatous Disease-associated Colitis Trial run by the NIAID (OpenBiome FMT product FMP250)
Recruiting
- Chronic Granulomatous Disease-associated Colitis
- OpenBiome FMT product FMP250
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 19, 2022
Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)
Recruiting
- Chronic Granulomatous Disease
- CGD
- JSP191
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 5, 2023
Granuloma, Tracheostomy Trial in Aurora (Betadine, Silver Nitrate, Hydrocortisone Butyrate Cream, 1.0%)
Completed
- Granuloma
- Tracheostomy
- Betadine
- +2 more
-
Aurora, ColoradoChildren's Hospital Colorado
Aug 16, 2021
Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)
Active, not recruiting
- Chronic Granulomatous Disease Transplant
- Alemtuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Chronic Granulomatous Disease, Infection Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (gp91
Recruiting
- Chronic Granulomatous Disease
- Infection
- gp91 Grans
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 26, 2022
Chronic Granulomatous Disease, Inflammatory Gastrointestinal Disease, Inflammatory Skin Disease Trial run by the NIAID (XELJANZ
Enrolling by invitation
- Chronic Granulomatous Disease
- +3 more
- XELJANZ (tofacitinib)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Anaplastic Large Cell Lymphoma, ALK-Positive, Inflammatory Myofibroblastic Tumor, Other Solid Tumor Trial in Utrecht
Recruiting
- Anaplastic Large Cell Lymphoma, ALK-Positive
- +2 more
-
Paris, France
- +1 more
Sep 27, 2022
Vitamin D3, Chronic-granulomatous Disease, BCG Trial in Shanghai (Vitamin D3, Traditional treatment of CGD and TB)
Recruiting
- Vitamin D3
- +2 more
- Vitamin D3
- Traditional treatment of CGD and TB
-
Shanghai, Shanghai, China
- +1 more
Mar 21, 2022
Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)
Recruiting
- Chronic Granulomatous Disease
- Sirolimus
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 23, 2022